Keros Therapeutics Inc. (KROS)
11.17
-0.05 (-0.45%)
At close: Mar 03, 2025, 12:31 PM
Keros Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 559.93M | 331.15M | 279.05M | 230.04M | 265.88M | 7.02M | 23.26M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 1.21M | 1.33M | 1.33M | 115K | 115K | 501K |
| Other Long-Term Assets | 3.5M | 2.05M | 2.12M | 82K | n/a | n/a | n/a |
| Receivables | 2.74M | 1.09M | 841K | 18M | 216K | 922K | n/a |
| Inventory | n/a | n/a | -841K | 3.06M | 1.47M | 759K | n/a |
| Other Current Assets | 26.22M | 15.05M | 5.88M | 3.2M | 1.63M | 985K | 2.27M |
| Total Current Assets | 588.89M | 347.29M | 285.77M | 251.44M | 267.73M | 8.93M | 25.53M |
| Property-Plant & Equipment | 23.49M | 19.47M | 17.57M | 2.4M | 1.6M | 1.91M | 1.38M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 26.99M | 22.73M | 21.01M | 3.81M | 1.72M | 2.03M | 1.88M |
| Total Assets | 615.89M | 370.02M | 306.78M | 255.25M | 269.44M | 10.96M | 27.41M |
| Account Payables | 4.6M | 5.45M | 3.34M | 3.65M | 2.15M | 2.09M | 501K |
| Deferred Revenue | n/a | n/a | n/a | 7.13M | 4.39M | 1.92M | 10M |
| Short-Term Debt | 1.98M | 1M | 910K | 1.72M | 846K | 376K | 166K |
| Other Current Liabilities | 20.87M | 17.92M | 12.25M | 6.37M | 4M | 1.98M | 518K |
| Total Current Liabilities | 27.45M | 24.37M | 16.55M | 11.85M | 7.18M | 4.49M | 11.47M |
| Long-Term Debt | 16.88M | 13.44M | 25.62M | 462K | 952K | 899K | 622K |
| Other Long-Term Liabilities | n/a | n/a | -12.81M | -231K | -414K | 5.08M | 2.56M |
| Total Long-Term Liabilities | 16.88M | 13.44M | 12.81M | 231K | 538K | 1.02M | 3.19M |
| Total Liabilities | 44.33M | 37.81M | 29.36M | 12.08M | 7.72M | 5.5M | 14.65M |
| Total Debt | 18.86M | 14.44M | 13.27M | 1.09M | 899K | 1.27M | 788K |
| Common Stock | 4K | 3K | 2K | 2K | 2K | 2K | 1K |
| Retained Earnings | -568.78M | -381.43M | -228.43M | -123.75M | -65.01M | -19.65M | -7.31M |
| Comprehensive Income | n/a | 0.00 | -0.00 | -0.00 | -269.44M | -19.94M | -246K |
| Shareholders Equity | 571.55M | 332.21M | 277.42M | 243.17M | 261.72M | 5.45M | 12.76M |
| Total Investments | n/a | 1.21M | 1.33M | 1.33M | 115K | 115K | 501K |